
Quarterly Result14 Aug 2026, 07:21 pm
Auro Laboratories declares Unaudited Q1 FY27 Results
AI Summary
Auro Laboratories Limited has announced its Unaudited Financial Results for the quarter ended June 30, 2026. The Board of Directors approved these results, which were recommended by the Audit Committee. The company will publish the results in newspapers in due course. The financial results were prepared in accordance with Indian Accounting Standards (IndAS 34) and SEBI (LODR) Regulations, 2015. The company operates in a single segment, Pharmaceuticals.
Key Highlights
- Unaudited financial results for Q1 FY27 declared.
- Board of Directors approved the results.
- Results recommended by the Audit Committee.
- Prepared as per IndAS 34 and SEBI (LODR) Regulations.
- Company operates in a single 'Pharmaceuticals' segment.
Price Impact
More from AUROLAB